Global Laxatives 麻豆原创 Research Report 2023

Publication ID:

PB502233284

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Laxatives are substances that loosen stools and increase bowel movements. They are used to treat and/or prevent constipation. Laxatives vary as to how they work and the side effects they may have.
Highlights
The global Laxatives market was valued at US$ 5081.9 million in 2022 and is anticipated to reach US$ 6593.2 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Bulk-forming laxatives, also known as roughage, are substances, such as fiber in food and hydrophilic agents in over-the-counter drugs, that add bulk and water to stools so that they can pass more easily through the intestines (lower part of the digestive tract). Emollient laxatives, also known as stool softeners, are anionic surfactants that enable additional water and fats to be incorporated in the stool, making it easier for them to move through the gastrointestinal tract.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Laxatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Laxatives.
The Laxatives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Laxatives market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Laxatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AstraZeneca
Boehringer Ingelheim
Bayer
GlaxoSmithKline
Abbott Laboratories
Takeda Pharmaceutical Company
Braintree Laboratories
Purdue Pharma
Sucampo Pharmaceuticals
Segment by Type
Hypertonic Laxative
Lubricating Laxative
Stimulant Laxative
Volumetric Laxative
Swelling Laxative
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Laxatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Laxatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Laxatives 麻豆原创 Overview
1.1 Product Overview and Scope of Laxatives
1.2 Laxatives Segment by Type
1.2.1 Global Laxatives 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Hypertonic Laxative
1.2.3 Lubricating Laxative
1.2.4 Stimulant Laxative
1.2.5 Volumetric Laxative
1.2.6 Swelling Laxative
1.2.7 Others
1.3 Laxatives Segment by Application
1.3.1 Global Laxatives 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Laxatives 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Laxatives Revenue 2018-2029
1.4.2 Global Laxatives Sales 2018-2029
1.4.3 Global Laxatives 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Laxatives 麻豆原创 Competition by Manufacturers
2.1 Global Laxatives Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Laxatives Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Laxatives Average Price by Manufacturers (2018-2023)
2.4 Global Laxatives Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Laxatives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Laxatives, Product Type & Application
2.7 Laxatives 麻豆原创 Competitive Situation and Trends
2.7.1 Laxatives 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Laxatives Players 麻豆原创 Share by Revenue
2.7.3 Global Laxatives 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Laxatives Retrospective 麻豆原创 Scenario by Region
3.1 Global Laxatives 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Laxatives Global Laxatives Sales by Region: 2018-2029
3.2.1 Global Laxatives Sales by Region: 2018-2023
3.2.2 Global Laxatives Sales by Region: 2024-2029
3.3 Global Laxatives Global Laxatives Revenue by Region: 2018-2029
3.3.1 Global Laxatives Revenue by Region: 2018-2023
3.3.2 Global Laxatives Revenue by Region: 2024-2029
3.4 North America Laxatives 麻豆原创 Facts & Figures by Country
3.4.1 North America Laxatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Laxatives Sales by Country (2018-2029)
3.4.3 North America Laxatives Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Laxatives 麻豆原创 Facts & Figures by Country
3.5.1 Europe Laxatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Laxatives Sales by Country (2018-2029)
3.5.3 Europe Laxatives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Laxatives 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Laxatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Laxatives Sales by Country (2018-2029)
3.6.3 Asia Pacific Laxatives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Laxatives 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Laxatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Laxatives Sales by Country (2018-2029)
3.7.3 Latin America Laxatives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Laxatives 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Laxatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Laxatives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Laxatives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Laxatives Sales by Type (2018-2029)
4.1.1 Global Laxatives Sales by Type (2018-2023)
4.1.2 Global Laxatives Sales by Type (2024-2029)
4.1.3 Global Laxatives Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Laxatives Revenue by Type (2018-2029)
4.2.1 Global Laxatives Revenue by Type (2018-2023)
4.2.2 Global Laxatives Revenue by Type (2024-2029)
4.2.3 Global Laxatives Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Laxatives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Laxatives Sales by Application (2018-2029)
5.1.1 Global Laxatives Sales by Application (2018-2023)
5.1.2 Global Laxatives Sales by Application (2024-2029)
5.1.3 Global Laxatives Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Laxatives Revenue by Application (2018-2029)
5.2.1 Global Laxatives Revenue by Application (2018-2023)
5.2.2 Global Laxatives Revenue by Application (2024-2029)
5.2.3 Global Laxatives Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Laxatives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Laxatives Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Laxatives Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Laxatives Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Laxatives Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Corporation Information
6.5.2 Abbott Laboratories Description and Business Overview
6.5.3 Abbott Laboratories Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Laboratories Laxatives Product Portfolio
6.5.5 Abbott Laboratories Recent Developments/Updates
6.6 Takeda Pharmaceutical Company
6.6.1 Takeda Pharmaceutical Company Corporation Information
6.6.2 Takeda Pharmaceutical Company Description and Business Overview
6.6.3 Takeda Pharmaceutical Company Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Takeda Pharmaceutical Company Laxatives Product Portfolio
6.6.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.7 Braintree Laboratories
6.6.1 Braintree Laboratories Corporation Information
6.6.2 Braintree Laboratories Description and Business Overview
6.6.3 Braintree Laboratories Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Braintree Laboratories Laxatives Product Portfolio
6.7.5 Braintree Laboratories Recent Developments/Updates
6.8 Purdue Pharma
6.8.1 Purdue Pharma Corporation Information
6.8.2 Purdue Pharma Description and Business Overview
6.8.3 Purdue Pharma Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Purdue Pharma Laxatives Product Portfolio
6.8.5 Purdue Pharma Recent Developments/Updates
6.9 Sucampo Pharmaceuticals
6.9.1 Sucampo Pharmaceuticals Corporation Information
6.9.2 Sucampo Pharmaceuticals Description and Business Overview
6.9.3 Sucampo Pharmaceuticals Laxatives Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sucampo Pharmaceuticals Laxatives Product Portfolio
6.9.5 Sucampo Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Laxatives Industry Chain Analysis
7.2 Laxatives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Laxatives Production Mode & Process
7.4 Laxatives Sales and 麻豆原创ing
7.4.1 Laxatives Sales Channels
7.4.2 Laxatives Distributors
7.5 Laxatives Customers
8 Laxatives 麻豆原创 Dynamics
8.1 Laxatives Industry Trends
8.2 Laxatives 麻豆原创 Drivers
8.3 Laxatives 麻豆原创 Challenges
8.4 Laxatives 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AstraZeneca
Boehringer Ingelheim
Bayer
GlaxoSmithKline
Abbott Laboratories
Takeda Pharmaceutical Company
Braintree Laboratories
Purdue Pharma
Sucampo Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.